Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas and other neoplasms.
Stolinsky, D C
Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas and other neoplasms. [electronic resource] - Cancer chemotherapy reports - 477-80 p. digital
Publication Type: Clinical Trial; Journal Article
0069-0112
Clinical Trials as Topic
Drug Evaluation
Drug Therapy, Combination
Female
Humans
Lymphoma--drug therapy
Neoplasms--drug therapy
Sarcoma--drug therapy
Time Factors
Vinblastine--adverse effects
Vincristine--adverse effects
Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas and other neoplasms. [electronic resource] - Cancer chemotherapy reports - 477-80 p. digital
Publication Type: Clinical Trial; Journal Article
0069-0112
Clinical Trials as Topic
Drug Evaluation
Drug Therapy, Combination
Female
Humans
Lymphoma--drug therapy
Neoplasms--drug therapy
Sarcoma--drug therapy
Time Factors
Vinblastine--adverse effects
Vincristine--adverse effects